Galectin-9 expression on tumour-associated immune cells is associated with favourable clinicopathological features and better outcomes in oral squamous cell carcinoma

INTRODUCTION: Galectin-9, a β-galactoside-binding protein, might be a potential target in cancer personalized therapy, but contradicting data exist regarding its prognostic significance in malignancy. Previous studies showed low or absent expression of galectin-9 on tumour cells of oral squamous cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Pęksa, Rafał, Kunc, Michał, Piątek, Michał, Radecka, Barbara S., Jereczek-Fossa, Barbara Alicja, Starzyńska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230243/
https://www.ncbi.nlm.nih.gov/pubmed/37266336
http://dx.doi.org/10.5114/wo.2023.127142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230243/
https://www.ncbi.nlm.nih.gov/pubmed/37266336
http://dx.doi.org/10.5114/wo.2023.127142

Ejemplares similares